Resmed (RMD) Gets a Hold from RBC Capital
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.
RBC Capital Reaffirms Their Hold Rating on HUB24 Limited (FSB)
In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...
Triton International Announces Pricing of Public Offering of Series F Preference Shares
Triton International Limited (the "Company" or "Triton") today announced the pricing of an underwritten offering of 6,000,000 of the Company’s 7.625% Series F Cumulative Redeemable Perpetual ...
DA Davidson maintains Buy on Zillow with $80 target
Zillow Group (NASDAQ:ZG) stock maintained a Buy rating and an $80.00 price target from DA Davidson. The firm's endorsement ...
Higher capital requirements for UBS will raise costs for others, CEO says
Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...
Investors Chronicle19h
Can Tesco maintain its grip on Britain's shoppers?
Britain’s biggest supermarket chain used data to gain an edge, but as rivals start to catch up, Michael Fahy looks at whether its growth prospects are worth buying into ...
Tesla is acting like an AI stock. Should investors focus more on auto trends?
That helps underscore UBS analyst Joseph Spak's belief that investors don't really view Tesla (TSLA) as a carmaker any more. "We can almost definitively say the market doesn't treat TSLA like an auto ...
Bernstein raises RTX Corp price target to $136 on Q4 results
Bernstein analysts have increased the price target on RTX Corp. (NYSE:RTX) to $136.00, up from the previous $131.00, while maintaining a Market Perform rating on the stock. The adjustment follows ...